Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's my point. If they worked on the web site like any project I work on, it starts by researching what other companies have done that looks good, what doesn't, what works, and what doesn't work. Don't have anything that's an obvious red flag.
Put as many brain storming ideas together on a list as you can, toss out what you don't want to use, personalize it to your own brand, and improve on what others have done to make it the newest, latest, most current and best you are capable of making it. Just having it isn't enough. Why not do it so it is as good as you can make it?
Go to any competitors' web site and you'll see what I mean. There are a lot they can improve upon ... from the other web sites ... and their own.
As a group here, we could compile a list of "preferred changes" and send it to them, but I'm not going to waste my time. They are pretty evident, like ... the U-Tube videos of the beer being produced ... start the buzz with the very start of the beer and follow it all the way to the consumers in all the different states where the beer is being sold. There's a story unfolding right now that a new person to Rheingold doesn't know ... tell it ... show it. Even as simple as your own posted picture holding the "brand" in front of a store is along those lines. What's in it, and testimonials from customers, distributors and retailers. Visuals tell the story. Get more of them.
As far as a "long" having a beef with the web site, my posts in total are generally pretty much middle of the road, recognizing and acknowledging the negatives with a more major focus on the obvious positive this pink presents to the public. At some point pinks slip away into oblivion, sometimes after never realizing anyones' dreams.
DKAM after a longer than anticipated wait for me, is following through on why I originally bought the stock ... they were going to reintroduce Rheingold. That's a gigantic star in my book since so many pinks fail to deliver on their primary objective.
Too many people bought into the DKAM story years before me. My interest was only peaked by Rheingold, and even then I bought in way too early.
I was following, focused and invested in GCFB and HOOK long before DKAM. Their stories are so much more compelling since they already have happier tales to tell. I also bought into ROX, and that story is just a bore. I was hoping DKAM could follow the same path as the former, though the later would be a major improvement from where we are right now too. Small breweries can get it done!
Now that DKAM's roll-out of Rheingold is happening, I am very pleased to see it expanding into other markets, and being restocked in my home area, the only one I can attest to. You have noted it is happening in Georgia too. Other board members in areas with distribution should post what's happening in their area too.
Expanding distribution and revenues are the only things that can drive this company forward and they have finally set off on the right path. That's exciting. Their story is more compelling now than it was 12 months ago.
Every company has a mathematical breakeven point. DKAM's current fixed expenses are unreasonably too high for that breakeven to be low enough in the near term to break above it. That said, DKAM has sputtered for years, failing every time to gain traction with its products, but now they are finally increasing revenues with a core product in the most popular alcoholic beverage segment with the greatest potential of any product in their entire line.
Debt, dilution, legal problems, and payroll that's not reflective of performance are major negatives every investor should look at.
I am willing to subjugate those problems to the picture unfolding before our eyes ... Rheingold is in major liquor stores in my area that I normally shop in, so I see it all the time, and will be buying a few more cases today.
Without revenues every company dies. DKAM has right now, maybe their last and best chance to make a name for itself and profits. They may sell enough beer to generate enough revenue to become profitable in 12 - 24 months, in spite of all the negatives associated with the people running it.
The more beer they sell, the longer and louder I will applaud them. Quarter over quarter revenue increases with a narrowing gap of loses will attract long term investors and short term traders. Revenues generate buzz and I can hear it. Hopefully the BUZZ gets a lot louder with the June's financials when the second 3 month period can be compared to the first 3 month period of Rheingold's rebirth.
I sure wish, "under where to find Rheingold", they listed all of the retail outlets so people could more easily find the beer.
If they used a focus group they could build a perfect web site. It's not bad, but it could be soooooo much better.
There's no good reason why it's not perfect.
cargo_hauler Share Tuesday, February 15, 2011 8:20:10 PM
Re: None Post # of 57008
Gotta love the NEW Rheingold website...
http://www.rheingoldbrewingcompany.com/home.html
1) How did the after hours trade happen if they are not eligible to do it there?
2) Mr. Bill, I see the 3 mil to the right ... do you know what it is though? Was a price associated with it? Did it actually trade, or is it in limbo?
kezzek Share Tuesday, February 15, 2011 5:03:55 PM
Re: FUNMAN818 post# 56994 Post # of 56996
Form T trades are broker reported after hour trades (not on the regular AH market which DKAM is not eligible for).
Not sure about any 3.1 million trades, all I see is one 962K trade at $.0048 at 4:12, the form T trade.
Mr. Bill Share Tuesday, February 15, 2011 5:08:37 PM
Re: kezzek post# 56995 Post # of 56996
Go look at IHUB Trades - the 3M trade is quite weird
It does not show but shows out to the right after hours
What is form T, and what does the 3,111,810 represent?
Mr. Bill Share Tuesday, February 15, 2011 4:45:20 PM
Re: FUNMAN818 post# 56991 Post # of 56993
Wow look at after hour FORM T SELLS - SCARY
962K and 962K but even scarier is a 3,111,810 trade as ?
Looks like MMs are dumping end of day below the bid to cover all the trading for the day
Yikes - major BADNESS
http://ih.advfn.com/p.php?pid=trades&symbol=DKAM
Wow, on a day with little action, those were a couple of big trades to close out the day.
I wonder whose buying?
With every day that passes and I see new posters here, I really feel badly for all of you still holding shares.
Of course you can buy tons of "cheapies". I think you'll be able to buy .001's soon enough, at 4 times less than right now.
I have so little faith in the company, that right now with today's volume already over 8,000,000, it wouldn't surprise me to learn in hindsight that SFIO was dumping as much stock as they possibly could, to raise as much as they possibly could before they legally bankrupt the company to cover their backsides.
But for gosh sakes, if the company ever comes forward and acts like an honest, transparent publicly traded company, shows some revenue increases that correspond to their PR's announcing contracts, sales and shipments, you'll be able to look back, say, how could I have ever doubted them, and happily jump back in at a penny. I will, even if I miss jumping back in before that.
But the handwriting is on the wall. It's not happening.
Even today's posts are rehashing what we went over from August through January. Anybody new here should go back and read the whole history. It's been that many months already that it became clear SFIO was deceiving us, with all their PR's.
They could have bought off the shelf web site software to put up a better web site, and spent their stock advertising money on some google advertising. But they would have only done that if their intent was really to sell product.
It's too bad it has happened, but nobody has to stick around until bankruptcy, and everybody can jump back in if the company ever proves they are run by honest businessmen; showing their financial statements that prove the sales they claimed to have made. Forget all their excuses, they claimed to have shipped the product, and a lot of it. Show me the money!
So far they never announced anyone paid for the product and as far as revenues, all we know is they gained access to about $800,000 in financing. I really can't image who they hoodwinked to give them the second loan; not when all of us were chasing down the dirt we found, and chasing them from state to state.
tocororo's post and link were great. It so clearly says what we all learned before I sold my stock, which I did the next day, after passing judgement on the website and finally on their business practices. I only wish I didn't wait as long.
You better grab for your oxygen masks when they drop from the bulkhead.
So who is going to be the last man holding shares.
tocororo Share Tuesday, February 15, 2011 2:15:04 PM
Re: None Post # of 15180
http://www.pinkinvesting.com/article/view/Reluctant-To-Disclose-Financials-Smokefree-Innotec-Inc.-SFIO.PK-Relies-On-Unsuccessful-Advertising-Campaigns_957
I think like you said if they sell 50 - 70 units, the units will start selling themselves just through the growing reputation.
However I believe it will take only a meager amount of sales, in the single digits, for the stock to take off. It's the show me factor. The revenues from each unit will be substantial, and start wow'ing people.
If only half of the distributors sold one unit in the first 12 months, I think the buzz will be loud and clear.
Surgical testimonials will spur more demand, and then VKNG's price per share should launch.
Filling the pipeline may take time, but I would like to see the first order followed by another sooner rather than later.
Once they start to happen, a cannot imagine major hospitals letting others get ahead of them on the technological surgical curve.
3-D surgical technology will capture a growing market share because "better" with regards to health in the USA will prevail.
Offering it during surgery is the natural progression after examination.
It's happening all around us. Viking's niche just needs to grab a foothold.
Here's a bit of related news:
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Selenia Dimensions 3-D technology addresses many of the limitations of conventional mammography
BEDFORD, Mass., (February 11, 2011) - Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company received approval from the U.S. Food and Drug Administration (FDA) for its Selenia Dimensions digital breast tomosynthesis system (Dimensions 3-D).
Mammography systems using conventional 2-D imaging have limitations caused by tissue overlapping tissue in the breast that may hide lesions or cause benign areas to appear suspicious. Clinical trials using Hologic's Dimensions 3-D system showed measurable improvement in clinical performance over conventional mammography. These trials also showed significant gains in specificity - the confidence to rule out cancer without recalling the patient for further study - and other benefits including improved lesion and margin visibility and the ability to accurately localize structures in the breast. The combination of measurable improvements in accuracy and detection, and improved sensitivity, makes the Dimensions 3-D system a superior system vs. conventional digital mammography systems.
"We are extremely proud to be the first company to receive FDA approval of a 3-D digital mammography system and to offer women this ground-breaking , superior imaging technology," said Rob Cascella, President and Chief Executive Officer. "Our Dimensions 3-D takes advantage of all of the benefits of digital mammography and quite simply makes it better with the combination of fast, high quality 3-D breast imaging. We believe tomosynthesis has the potential to change how screening and diagnostic mammography is performed, and over time will prove invaluable to the earliest possible detection of breast cancer and in the reduction of unnecessary diagnostic interventions."
According to Jay Stein, PhD, Hologic co-founder and Chief Technology Officer, "Tomosynthesis scans can be performed quickly with Dimensions. This means enhanced performance not just for diagnostic problem solving, but in everyday routine screening. Over the next several years we view Dimensions as a platform technology for other imaging modalities to aid in the fight against breast cancer."
Hologic's Dimensions 3-D system is available commercially in more than 40 countries including countries in Europe, Latin America and Asia. In North America, commercial systems are already installed in Canada and Mexico.
About Breast Cancer
One in eight American women will develop breast cancer sometime in her lifetime.1 In 2009, an estimated 192,370 new cases of invasive breast cancer were diagnosed among American women, as well as an estimated 62,280 additional cases of in situ breast cancer.2 Over 40,000 American women died from breast cancer in 2009.3 Only lung cancer accounts for more cancer deaths in American women. The stage at which breast cancer is detected influences a woman's chance of survival. If detected early, the five-year survival rate is 98 percent.4 At this time, there is no sure way to prevent breast cancer, which is why regular mammograms starting for most women at age 40 are so important.5
About the Dimensions 3-D System
The Company's Dimensions 3-D mammography system is a new method for breast cancer screening and diagnosis. Unlike prior-generation mammography systems which generate two-dimensional images, breast tomosynthesis produces three-dimensional images which are intended to reveal the inner architecture of the breast, free from the distortion typically caused by tissue shadowing or density. Tomosynthesis images are acquired with the breast held briefly in compression. The examination, which includes a 3-D tomosynthesis image in combination with a 2-D image, takes only seconds longer than a conventional 2-D digital mammogram at a total exam dose within current FDA guidelines. The 3-D scan results in a stack of thin high-resolution image slices intended to provide clear rendition of structures in the breast and their spatial relationship with the surrounding breast tissue. The images are displayed on a standard diagnostic workstation for review by the radiologist.
Dimensions 3-D software is a purchasable option on existing Selenia Dimensions 2-D systems. Enabling the 3-D capability on a Dimensions 2-D system involves a software key and adjusting a PC-board setting. There is no need for new hardware. Upright stereotactic biopsy and computer-aided detection are already cleared for use on the Company's 2-D Dimensions systems.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.
Hologic, Dimensions and Selenia, and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.
Revenues in pinks sometimes hardly ever materialize.
Lots of DKAM promises and announcements of iconic brands over the years failed to yield increasing revenues.
That's probably because like fad fashions and trendy restaurants, they come and go. I did not care about them before, and do not look forward to scarce promotional dollars being diverted towards anything new, and away from what is becoming DKAM's bread & butter.
In 2009 I bought my first shares of DKAM anticipating the Rheingold roll-out. It took more than a year longer than I thought it would, but it's been happening and expanding since September 2010. The footprint of states continues to grow.
Two guys have basically sold a brand and product to distributors totaling in a preannounced revenue release a number in the $200,000 range. If modest quarter over quarter revenue continues to increase, then the first full 4 quarters of revenues with Rheingold sales on the books for all three months of those quarters, will total in the neighborhood of one million dollars.
If Rheingolds advantageous price point and promotions help to increase brand awareness and loyalty, a steadily increasing sales trend should project into the future.
Lots of pinks don't make money and see their stock trading above DKAM's sub penny price. Increasing revenues offer the promise of a turn around.
So watch the next few 10Q's. They will tell the story if DKAM has a bright future. If it's a good bet in 3 months, it will be a better better in 6 months.
For now, it's wait and see. Buy when the story is to your advantage. The next two 10Q's will establish the trend.
Demo units ... it will be nice to read a PR telling us when the demo units have completely shipped to distributors, and some of their sales demonstrations begin.
If payments for the demo units really cover costs, then I wonder how long it will take for the distributors to sell the 1st, 2nd, 3rd, etc. machine?
If VKNG is really at that doorstep, why would Midsummer want to sell?
I'm waiting for the excitement.
The FUN part of this penny right now is revenues will show a jump of 150% - 200% in the next 10Q. With continued distribution expanding into a few more densely populated states, revenue will continue to naturally increase. There will also be a normal seasonal consumption uptick with the onset of summer in the following quarter. An announced promotional campaign is scheduled to start before April 1st; details are thin. Don't expect Clydesdale-like commercials. But expect something that helps support the brand.
Taken together, DKAM is likely to grow quarterly revenues from about 50K in the prior quarter to somewhere between 4 - 8 times that in the June 10Q. If distributor and retailer reorders continue, establishing a customer base, the product can gain a foothold to build upon from that point.
I have owned DKAM since 2009, was disappointed with the reverse split, the apparent continued dilution after the R/S, less than stellar management, and the longer than anticipated wait for Rheingold's roll-out to begin. Yet, the roll-out began impressively and continues. They did get that job done, and it was not easy. If it was, everyone would do it.
I have been buying Rheingold in CT, since it's initial September introduction, can personally attest that it is consistently restocked and available on the shelves every time I enter the stores, and that although it is not my preferred type of beer (I opt for heavier and hoppier flavor), Rheingold is comparable to PBR and other lighter type beers. I buy it to support the brand, wouldn't drink it if I thought it didn't taste good enough, wouldn't buy it if it wasn't priced as economically as it is, and would have sold the stock already if the beer I waited so long to come out was such a disappointment.
Another positive for the stock is, as expanding distribution continues, brand awarenes increases. More people are becoming aware of the stock, so there are more potential stock buyers out there.
Expenses are not likely to increase, other than the yet to be released consumer promotions and the variable expenses associated with increased production and distribution. We are all awaiting the results of an arbitration hearing that took place last month. If all remains the same, DKAM may be able to grow revenues and hopefully become profitable in the future.
Do your own DD. Read the last 10Q. It was very detailed.
Pauly,
Sorry for the delay to respond. I've been traveling.
I gave up on SFIO after waiting for about 18 months to see with my own eyes the results of what they announced was happening in Europe.
I made many increasingly larger and larger "buys" to average down.
You know my history of posts and feeling that management wasn't as forthright as the type of people I wanted to invest in. Yet I held and continuously bought throughout.
After I saw the long awaited web site, I lost 100% confidence. I sold everything at .0065.
I took my loss, licked my wound, and know that as the stock continues its decline, I can always jump back in if they ever introduce the e-cig and promote it. I have zero confidence in the Smokers Option. I took my FUN money and bought into another "penny" that preannounced a 150% ($150,000) quarterly revenue increase.
Right now I see SFIO's web changes done to satisfy "board member" comments and complaints. All told, they are acting like too small of a company and I just don't believe they're honest.
If they ever start to deliver and look promising to me again, I'll jump right back in. Why wouldn't I?
Guys, the handwriting is on the wall ... I was killed for pointing out the signs ... add them up ... SFIO is milking the cow before your eyes.
I ask you, what are you waiting for ... if something positive happens, you can always buy back in. Nothing is final.
I really wish you guys some luck here.
I lost my patience waiting toooooo long for SFIO to make a splash, put up a sexy website, grab a share of the e-cig market, and release financials showing anything close to even 10% of the sales numbers they projected a year ago from their European deals.
I moved into a company that just announced $200,000 in sales, an up-tick of about $150,000 ... there's some hope and 7,000,000 shares traded today.
If SFIO shows any FACTUAL promise, I'm sure I'll become positive about SFIO's prospects again and buy back in.
I hope someone posts sooner rather than later that they received the product they already ordered from SFIO.
Welcome back. Something is brewing at Rheingold.
Mr. Bill, sell your 15,000,000 shares on the big bounce.
Mr. Bill, you said you didn't own shares, and I am not saying you secretly do. If you start to sarcastically throw around numbers to cast doubt on whether you do or you do not own shares, than doubt will be in play.
Other people bought about 15,000,000 shares in the past two days. You warned them all. They either didn't read your warnings or they didn't care. They still bought.
I just wonder who they are and what they know.
Kezzek, I don't get it if it's day traders; they expect a worthwhile bounce?
The only thing I can think is the buyers believe or know the $200,000 was DKAM's shipping price and extended that means about (mind you I say about), 100,000 cases shipped.
To some that must be a lot; I don't know?
Mr. Bill, you show weakness in your arguement when you show no willingness to acknowledge DKAM shares, a lot of them, are being bought. No one can sell without a buyer, right?
I've heard the negatives, but in two days nearly 15,000,000 shares were bought as the price dipped. More buying is going on now than has taken place over the past few months on any given day.
I am just wondering who they are and what they know that you and I do not know?
The revenues satisfied the buyers. Their projections were obviously lower than the announced numbers. Fill the board with all the negatives you want, but the buyers are stepping forward.
Bid or Ask, they're buying, and today's volume may top yesterday.
They don't care about dilution or where the shares are coming from, otherwise they wouldn't be buying.
Those folks have "bet" more than $30,000 today and yesterday. I'm wondering who is so anxious to "buy" and why?
What do they know that you have not already told them.
Not too phased or worried about dilution. A lot of shares are being bought by people over the past few days.
They're either "traders", existing shareholders looking to average down, people involved in the supply chain, or new people being exposed to the retail product. Are there other groups I am not considering.
Who do you think the buyers are?
The PR didn't mention Ky either.
I'm bummed ... announced revenue below my estimates and the PR made no mention of Texas.
Looking forward though to advertising promotions and some gorilla marketing to kick in.
Some people sold a whole lot of stock today, while others are really starting to accumulate, I assume on the thoughts of better news.
I haven't seen volume this high since, well I can't remember when.
Funny if some of the buyers start turning out to be distributors selling the beer with more info than we have.
I'm just saying ... no one gets to sell without a buyer.
But it wasn't me.
Red Flags ... a few of us were raising them for months ... some pinks fade away without telling anyone they're gone ... just make sure you're not the last trader holding the most shares.
You're technically right. They could still raise more than half a million dollars at that price.
I'm just thinking that from a practical point of view, if they don't have increasing revenues so they can start paying expenses with cash, before it comes time that they have to do another RS, DKAM will be long gone.
From another viewpoint, the diluted shares are either payments for services to vendors who do not have to disclose they are selling (so the shareholders really are paying the vendor), or they are management's shares, that they bought on the open market pre-RS (which I doubt they are selling). Otherwise the 30 Million authorized in the employee compensation plan was disclosed.
When the next 10Q comes out, we'll see how bad, or good it is.
I don't think anyone buying DKAM is unaware of dilution, right?
Even a penny player should look at a company's financial statements if they are available. DKAM's dilution is public info. Their last financial statement was very complete and detailed.
If anyone is only basing their investment plays on investorhub boards, they should seek help. You've been here so much longer than me, so you may know some people really do base their decisions on these boards. That's why you provide a service.
My concern is basically if I am getting truthful information from the company so my investment decisions can be based on a level playing field. You know from my posts over the weekend that was not the case at another company. I was frustrated.
Some posters on this board were very helpful and kind. In that company's case just today, at otcmarkets.com an Insider Trading Warning was posted on that companies listing. Most of the people on that board are still pumping and buying. I think that is sad.
So back to DKAM, no one forced the buyers to buy today. They were the ones to set the stock's value. It's either a penny player who gave up, PK or vendors who got less than they wanted.
If it goes down some more, so be it. If it goes to .001 that will put an end to dilution, and you will be bored, but you can have hope ... it could go even lower than that.
But when the revenues are reported, and I expect they will be between $250,000 - $350,000, you will have to get all wound up again, and rev up your message machine.
The only thing, there will be another side of the story unfolding in front of peoples' eyes. Like the facts about dilution that are repeated here and in DKAM's financial statements, the reported revenue numbers won't lie.
The next earnings come out on or about March 21, 2011. Check the web site for the press releases and news beforehand, and then watch for the 10Q report. You'll have a good idea if it will look good just by looking at the expanding distribution network.
Today's selling was heavy; so many lots were 100,000+ shares. Of course it could have been you, or it was a vendor who was converting their "payment in shares" to cash. Nonetheless, someone was happy to buy them up.
See you soon.
Griff100, balanced is fair enough. Everyone gets to make better decisions, here and in life. The more informed the better.
Acknowledging that DKAM's past was pretty much a "long" investors apocalypse is self evident and something I have to live with each day.
However not acknowledging there actually are some positives happening is not being balanced at all.
Until the next 10Q, I really don't care as I have stated before if the stock didn't trade a share. I like seeing it look good, but if it didn't trade until we had new news to discuss, I would be fine with that. If it went down to .001 I would have to buy DKAM because when the revenues are reported, it will bounce just because that's the nature of these penny stocks.
So I am fine with whatever is said on this board. Mr. Bill has a point to make. I just think the past is seen with great clarity, and the future opportunities are brewing right now. A different perspective of what's going on more akin to the current circumstances is perfectly reasonable and balanced.
DKAM really may not make it. They may not come close to my own conservative revenue estimates of $250,000 - $350,000 in which case everything will be a great disappointment.
However if the report is within the range, there really can be no dispute something better will be going on at DKAM.
After the e-cig comes out, expect a reverse split because management will need to sell more shares if they ever want to have any money to advertise the brand.
And sadly for all of you guys with giant bags of shares, you actually better hope they do it because they have no money to advertise now, and they absolutely have to advertise.
That said, if a tree falls in the woods and no one hears it, does it actually make a sound is a perfect analogy for what I am saying. If SFIO improves their web site and brings out all the products they have to stock to satisfy what the market really wants to buy now, it won't matter that they have the product and the web site if they cannot afford to advertise it.
Walzy, the guys who post negative stuff are not lying about it. That info is also in front of everyone's eyes. I'm just not fixated on what REALLY went wrong in the past. I don't have a choice either, do I?
Once Rheingold came out in my local stores in Sept 2010, I was a happy shareholder, trying to recoup my "unrealized lost investment" by saving about $20 on every case of beer I bought. I've been buying Rheingold since then instead of my preferred heavier and hoppier beers.
I need to buy quite a few more cases to reach my goal, but before I know it, I will be able to smile and say "my shares are free". That's my investment philosophy with DKAM right now, and I say it with a grin on my face.
You bring up a very interesting point about trying to build the Rheingold brand to sell. It's reasonable, but I wouldn't buy DKAM based on that; it's really a wing and a prayer.
Another company I bought a few years ago whose ticker is HOOK actually falls into the category more along the lines of what you are thinking and is not pie in the sky. The investment philosophy is leave management alone to do their thing; control distribution.
I bought the stock because I liked the beer, insider buying was going on, and the following info.
Holder Name Shs Held $ Market Value %Out Fully Diluted Shs Rpt Date
Anheuser-Busch Companies Inc 6,069,047 40,359,164 32.3 6,069,047 12-03-10
There has to be a compelling reason for a big company to do it. I think DKAM has a long way to go before they can present a good enough reason for anyone to think of doing it, but DKAM is hooked up with the same distribution network, so anything is possible. I just don't think it's on the horizon. Rheingold is PK's golden ring. The other stuff is pretty meaningless. Why sell the good to keep the bad? That's the part of the business that turned everyone off.
It's happy hour, go pop open a Rheingold.
I'm pleased with today's action; honestly. My HUM was down $1.80 that's REAL money for anyone whose counting.
But I am not worried about it; I didn't sell it today either. HUM raised guidance for next year, and that's the way I am looking at DKAM too. Revenues are going up like the sun rises every day. When they drop again quarter-over-quarter I will be concerned.
Do you see my shoulders going up and down as a chuckle worrying about DKAM being down .0009, while some say the world is crashing around us.
I don't have to look for a silver lining to see what is right in front of everyones' eyes.
There was probably more trading (not just volume but actual trades) going on in the last week than in the previous month.
Some traders may even be making money on the spread everyday intraday.
Interest is rising, people are looking at DKAM, more will pay attention to the continuing state rollouts, because more people are drinking Rheingold.
Win or lose, this is a FUN ride right now. DKAM is selling hope with every case of Rheingold.
Large geographic distribution in Rheingold's case was necessary, it's a confidence booster, and it's impressive that it is happening. Give them credit for making it happen.
If Rheingold was only rolled out in NY metro, a whole contingent here would be saying they aren't rolling out enough product. No one wants it. They can't sell it outside of their base where people knew the name from years ago.
Don't forget, most of the people buying Rheingold in the 1960's are dead. That's not the market I want to target. DKAM needs more sales volume and they are generating it. That's fantastic and exciting.
A whole group is saying DKAM is producing Rheingold at negative margins. I highly doubt the model they used did not take into account that at revenue "x", Rheingold surpasses it's own production and distribution breakeven point. At that point it will contribute to DKAM gross profits.
A whole group is saying the distributors are desperate and they need to add the product to their portfolio to compete. That they lost out on other brands.
So what! It's to DKAM's advantage, because if the distributors thought Rheingold was a dog, they would not bother carrying it. If there were no distributors Rheingold would be dead in the water.
Lining up the distributors is what took so long, and consequently why I was so disappointed that when I first bought the stock in 2009, I thought the roll out would happen much sooner. If I knew what was happening I would have waited. I rode it all the way down through a reverse split. That said, I am in the hole looking up, but I am finally drinking the beer, and hope to ride the rising tide and float out of the hole.
Also, every distributor of every product, not just beer, has to be concerned that they aren't pushing failures. When they do, it makes them look bad, and makes it much harder for them to push "the next product", whatever that may be. Strategically, they have to care.
High expenses; no disagreement from me. They are unwarranted.
Dilution; we know it will happen. To what degree it is necessary and curtailed remains to be seen in the next 10Q. But some here are hanging their hat on that as the reason DKAM's price is under such pressure, and such a bad investment.
I say that DKAM is under so much pressure because they have lost so much money for years, been so bad at other product introductions, and right now do not present a compelling investment opportunity other than possibly in the future success of Rheingold. So why shouldn't a conservative investor just wait a few weeks for the next 10Q? They should.
But some aren't conservative, they're traders just looking to make some money on a bounce. That's why buying is going on. People who accepted shares for services instead of cash are probably selling them because they need the money. Traders are trying to buy as low as they can, and are hoping for some good revenue news to bounce demand and the stock upwards.
Daily / hourly watching the stock bounce; only traders care. Longs are hopping a bottom has finally been reached and revenues will encourage more people into actively trading DKAM. Increasing revenues may have put in the bottom. The .004 I thought would be reached last Friday, the day before Super Bowl weekend did not happen.
Increased volume increases interest and brings in more traders. For every share sold, there is a buyer of that share. After the 10Q comes out we will have a much better handle of what a share's value should be.
Don't like management; so what neither do I at the moment, but at the moment they are riding a wave. Getting up on the wave is the hardest part. I'll clap long and hard the longer they ride the wave, and if they turn an annual loser into a winner, I will applaud them. They will have risen to the same status as the analogy I have used in the past about the N.O. Saints; losers until they became winners.
Old news is good news ... I believe though the signing up of the MD distributor was announced a while back, no shipments were made to them ... I thought it was supposed to start later in the spring closer to the beginning of "resort season".
The PR wasn't clear on that, but in MI's case, the PR actually announced the shipment was taking place. It was also the first one to peg a dollar amount to it.
I am not sure if the information is going to be consistently released in the same manner. Actually I have no reason to know.
I too, along with others, believe DKAM stock will be under significant downward pressure, at the very least for the next 5 weeks prior to the release of the 10Q. It may continue to drop between now and then, bouncing before, in anticipation of the (hopeful) good news.
However, I also believe that investors watch for companies increasing their revenues while reducing losses (SEE MGI as an excellent example). That's why I feel good about the DKAM investment for now.
Investors like to see those two lines angling towards crossing each other. They believe the losses are under control, and better revenue prospects are on the foreseeable horizon.
I believe the next 10Q will indicate that, and continue the trend into the subsequent 10Q in June as the shipments to Oh, Ky, Md, Tx, and Fl begin to kick in.
As long as the original distributors continue to re-order these trends bode well for DKAM. It should strengthen interest.
The more research I do, the more I learn about what's really going on here. The road is coming to an end. Do anyone of you really want to be left with the last SFIO share?
Traders make so much more money in companies that actually sell a lot of product. Those companies don't have to make money, but they do generate millions in revenue always offering promise, so trading is active.
That's not SFIO.
Who here is really making on the average trading day more than enough for a good dinner that night.
SFIO paid $10,000 to pump the company, and spent virtually nothing on the web site. What does that tell you?
They've borrowed money twice in the past 12 months and don't have any sales to speak of. No distributor will answer a simply question, can you point me to some retailers where I can buy the product?
For anyone who wants to quit smoking and needs something in their hand and mouth, a 4" inch stick would be as good as Smokers Option and would never have to be replaced.
What good is a patent on anything if they can't deliver it. They told you the e-cig was selling for over a year, and now they cannot manufacture the very same components in the USA ... come on.
The more you guys keep accumulating and holding waiting for a bump, the closer you are coming to being the last man holding the most shares.
Kezzek,
Thank you very much.
FUNMAN
Totally agree with you.
I have pointed out some of those very same points before.
DKAM's expenses are outrageous. I run a lean and mean company and there is no reason why given DKAM's structure, they should be spending the way they do. It's time for them to suck it up and start running this company as if the goal is to turn it into a profitable company needing only $5,000,000 in revenue.
They'll make so much more money as soon as they show they are profitable by increasing revenues and getting expenses and debt under control.
Ironically, traders will also make a lot more money. When DKAM trades under $10,000 in a day in a narrow range, even the best trader can only make little more than "dinner money".
I have investments in a few companies with about 20,000,000 outstanding shares that I proudly say I bought really cheap. One of them now trades for $10 ... and is 80% - 90% institutionally owned.
That company filed with the SEC to sell another 2,000,000 shares priced at $9.50 ... sold them on Friday and the stock closed at $9.75.
They've never split since going public in 2003.
Even so, except for Friday when it was just crazy watching it sell all those shares, the stock sometimes trades with swings of as much as 50, 60 cents in a day. Now that can be a traders delight
There comes a time when being penny wise really is pound foolish. DKAM needs to realize this.
PK and traders can make so much more money with a really good company.
I understand that.
The situation I am referring to though requires an in depth discussion of another company which no one really wants on this board.
Their management had a history of fraud that was only discovered recently. Research proved their PR's were an exaggeration at best, or outright lies.
Then I learn this week they are paying to pump their company through a research company, and they are not delivering ... anything. They said they had world wide distribution agreements signed. Some of the distributors confirm the contracts. None can confirm a location where the product is being sold that they supplied. It's very complicated.
You and I both know that is not the case with DKAM. That other company is a complete fraud.
I'm drinking my Rheingold right now and watching UConn on ESPNU.
Right now all I want DKAM to do is sell more beer and take a realistic look at their expenses and tighten their belt ... as tough as that might be
cargo_hauler Share Saturday, February 05, 2011 6:33:30 PM
Re: FUNMAN818 post# 56489 Post # of 56492
All public companies use dilution to raise capital... That's why they go public, so they can use stock to raise capital to expand operations. The only time dilution is bad, is when there is no resultion expansion of sales, or never any profits.